Patents by Inventor Michael Gerster

Michael Gerster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7608705
    Abstract: The invention relates to particular oligonucleotides, pharmaceutical agents that contain these oligonucleotides, and to the therapeutic use thereof. The oligonucleotides are, in particular, capable of inhibiting the proliferation of pancreatic tumors. These oligonucleotides thus have a therapeutic potential for the treatment of pancreatic tumors. This can involve, in the broadest sense, an antisense therapy.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: October 27, 2009
    Assignee: Universitatsklinikum Schleswig-Holstein
    Inventors: Ernst Bayer, Inge Bayer, legal representative, Thomas Ketterer, Holger Kalthoff, Hendrik Ungefroren, Michael Gerster, Alexander Fiedler
  • Publication number: 20050019761
    Abstract: The invention relates to particular oligonucleotides, pharmaceutical agents that contain these oligonucleotides, and to the therapeutic use thereof. The oligonucleotides are, in particular, capable of inhibiting the proliferation of pancreatic tumors. These oligonucleotides thus have a therapeutic potential for the treatment of pancreatic tumors. This can involve, in the broadest sense, an antisense therapy.
    Type: Application
    Filed: September 28, 2001
    Publication date: January 27, 2005
    Inventors: Ernst Bayer, Inge Bayer, Thomas Ketterer, Holger Kalthoff, Hendrik Ungefroren, Michael Gerster, Alexander Fiedler
  • Patent number: 6447764
    Abstract: The invention relates to a method for isolating anionic organic substances from aqueous systems using polymer nanoparticles with cationic pH-sensitive surface groups. Extraction can be carried out directly from diluted solutions, biological media (blood plasma, serum, urine, etc.) and complex buffer systems (e.g. PCR preparations contain detergents) without prior derivatization of the samples or addition of binding buffers. After separation from the surrounding medium the conjugates of the corresponding substances and polymer nanoparticles obtained in this manner can be purified through additional washing steps and effectively desalinated. Owing to the pH-sensitivity of the basic surface groups, the bound substances can be released in a targeted manner after separation by modification of the pH of the medium. By using volatile bases contamination of the released samples with ionic residues can be avoided.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: September 10, 2002
    Assignee: Degussa AG
    Inventors: Ernst Bayer, Hans Fritz, Martin Maier, Jens Schewitz, Michael Gerster